Preview: Apollo Hospitals' Q2 seen strong on hospital, pharmacy momentum, analysts say

Apollo Hospitals Enterprise

04/11/2026 04:24

** Apollo Hospitals APLH.NS up 1.2% at 8,544 rupees ahead of Q2 results
** Hospital operator set for a strong quarter, aided by healthy patient volumes and rising hospital realisations, analysts say
** Apollo to report margin expansion and resilient demand helping sustain growth momentum into the second half, they add
** Kotak expects earnings growth to be driven by higher pricing and continued pharmacy momentum
** Motilal Oswal expects APLH's earnings growth to outpace peers, backed by strength across core businesses
** Avg rating of 27 analysts on stock at "buy"; median PT is 10,000 rupees - LSEG-compiled data
** YTD, stock up 21.1% vs Nifty 50's .NSEI 8.4% drop 


 (Reporting by Kashish Tandon in Bengaluru)
 ((Kashish.tandon@thomsonreuters.com))